Details of the Drug Reposition

General Information of This Drug (ID: DMFG8TI)

Drug Name
INCB00928   DMFG8TI
Drug Type
Small molecular drug

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
3 Phase 2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Myelodysplastic syndrome DISYHNUI 2A37 Phase 2 [1]
Multiple myeloma DISEWP9B 2A83 Phase 2 [1]
Anemia DISTVL0C 3A00-3A9Z Phase 2 [1]
------------------------------------------------------------------------------------

References

1 ClinicalTrials.gov (NCT04582539) To Assess the Safety and Tolerability of INCB000928 in Participants With Myelodysplastic Syndromes or Multiple Myeloma.. U.S. National Institutes of Health.